pargyline has been researched along with Dyskinesia, Drug-Induced in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
Excerpt | Relevance | Reference |
---|---|---|
"0 mg/kg) attenuated, in a dose-response fashion, the induction of stereotyped behavior and hyperactivity by pargyline (0." | 1.26 | Testosterone-attenuated stereotype and hyperactivity induced by beta-phenylethylamine in pargyline-pretreated rats. ( Freemark, M; Gillin, JC; Moja, EA; Stoff, DM; Wyatt, RJ, 1978) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Freemark, M | 1 |
Stoff, DM | 1 |
Moja, EA | 1 |
Gillin, JC | 1 |
Wyatt, RJ | 1 |
1 other study available for pargyline and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Testosterone-attenuated stereotype and hyperactivity induced by beta-phenylethylamine in pargyline-pretreated rats.
Topics: Animals; Behavior; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induce | 1978 |